The design and development of DaunoXome® for solid tumor targeting in vivo
- 1 March 1997
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 24 (2-3) , 133-150
- https://doi.org/10.1016/s0169-409x(96)00453-x
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Liposomes as Carriers of Cancer ChemotherapyDrugs, 1993
- Transcytosis of drug carriers carrying peptides across epithelial barriersBiochemical Society Transactions, 1989
- Phospholipid bilayers enhance the stability of leukotriene A4 and epoxytetraenes: Stabilization of eicosanoids by liposomesBiochemical and Biophysical Research Communications, 1989
- Mouse lewis lung carcinoma and hepatoma ascites treatment by combination of liposome chemotherapy and non‐specific immunotherapyInternational Journal of Cancer, 1984
- The effect of lipid composition of small unilamellar liposomes containing melphalan and vincristine on drug clearance after injection into miceBiochemical Pharmacology, 1983
- Drug Stability in Liposomal Suspensions: Hydrolysis of Indomethacin, Cyclocytidine, and p-Nitrophenyl AcetateJournal of Pharmaceutical Sciences, 1982
- The use of liposomes as enzyme carriers. I. Dependence of enzyme stability on the method of preparation.CHEMICAL & PHARMACEUTICAL BULLETIN, 1981
- Passage through the blood-brain barrier of thyrotropin-releasing hormone encapsulated in liposomesJournal of Pharmacy and Pharmacology, 1980
- Availability of liposome content to the nervous system. Liposomes and the blood-brain barrierBrain Research, 1980
- Pharmacokinetics of liposome-encapsulated anti-tumor drugsBiochemical Pharmacology, 1978